Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ibuprofen 600 Mg Immediate Release/Extended Release (IR/ER) Caplet Self-selection, Safety And Compliance Study

NCT01789606 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01789606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01789606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ibuprofen 600 Mg Immediate Release/Extended Release (IR/ER) Caplet Self-selection, Safety And Compliance Study
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
September 24, 2012
Completion date
June 3, 2013
Enrollment
1,083 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia